These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19205456)

  • 1. Anti-Lewis alloimmunization: report of seven cases.
    Nardozza LM; Lobo GR; Moron AF; Camano L; Araujo Júnior E; Guimarães Filho HA
    Clin Exp Obstet Gynecol; 2008; 35(4):311-2. PubMed ID: 19205456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How clinically important are non-D Rh antibodies?
    Healsmith S; Savoia H; Kane SC
    Acta Obstet Gynecol Scand; 2019 Jul; 98(7):877-884. PubMed ID: 30723901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital.
    Sánchez-Durán MÁ; Higueras MT; Halajdian-Madrid C; Avilés García M; Bernabeu-García A; Maiz N; Nogués N; Carreras E
    BMC Pregnancy Childbirth; 2019 Oct; 19(1):356. PubMed ID: 31615430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hospitalizations due to complications of pregnancy and maternal and perinatal outcomes in a cohort of pregnant women in the Brazilian Unified National Health System in São Paulo, Brazil].
    Moura BLA; Alencar GP; Silva ZPD; Almeida MF
    Cad Saude Publica; 2018 Feb; 34(1):e00188016. PubMed ID: 29412326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of Rh alloimmunization.
    Matijevic R; Grgic O; Klobucar A; Miskovic B
    Fetal Diagn Ther; 2005; 20(5):393-401. PubMed ID: 16113560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal mortality in Rh alloimmunized patients.
    Nardozza LM; Camano L; Moron AF; Chinen PA; Torloni MR; Cordioli E; Araújo Junior E
    Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):159-62. PubMed ID: 16854514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
    El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
    Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome for Rh-alloimmunized women.
    Nardozza LM; Camano L; Moron AF; da Silva Pares DB; Chinen PA; Torloni MR
    Int J Gynaecol Obstet; 2005 Aug; 90(2):103-6. PubMed ID: 15963998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome.
    Sankaralingam P; Jain A; Bagga R; Kumar P; Marwaha N
    Transfus Apher Sci; 2016 Aug; 55(1):153-8. PubMed ID: 27324408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization.
    Deka D; Dadhwal V; Sharma AK; Shende U; Agarwal S; Agarwal R; Vanamail P
    Arch Gynecol Obstet; 2016 May; 293(5):967-73. PubMed ID: 26493554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal-fetal alloimmunization: perinatal outcomes in a reference hospital in Northeastern Brazil.
    Duete ÚR; Brunetta DM; Araujo Júnior E; Tonni G; Carvalho FHC
    Rev Assoc Med Bras (1992); 2022 May; 68(5):670-674. PubMed ID: 35584494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.